Business · 08/09/2017Updated: 10/17/2026 · 1 min read
FDA Seeks Comments on Biologics Evaluation and Research Regulations
Summary
The FDA is seeking public input to review and potentially modify regulations related to biologics products, aiming to reduce regulatory burden while maintaining public health and statutory obligations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →